These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30721384)

  • 21. Is pure autonomic failure an early marker for Parkinson disease, dementia with Lewy bodies, and multiple system atrophy? And other updates on recent autonomic research.
    Muppidi S; Miglis MG
    Clin Auton Res; 2017 Apr; 27(2):71-73. PubMed ID: 28255741
    [No Abstract]   [Full Text] [Related]  

  • 22. When Do α-Synucleinopathies Start? An Epidemiological Timeline: A Review.
    Savica R; Boeve BF; Mielke MM
    JAMA Neurol; 2018 Apr; 75(4):503-509. PubMed ID: 29459985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.
    Savica R; Grossardt BR; Bower JH; Ahlskog JE; Boeve BF; Graff-Radford J; Rocca WA; Mielke MM
    JAMA Neurol; 2017 Jul; 74(7):839-846. PubMed ID: 28505261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG; Goedert M
    Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin nerve misfolded α-synuclein in pure autonomic failure and Parkinson disease.
    Donadio V; Incensi A; Piccinini C; Cortelli P; Giannoccaro MP; Baruzzi A; Liguori R
    Ann Neurol; 2016 Feb; 79(2):306-16. PubMed ID: 26606657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vivo Detection of Underlying Synucleinopathies: Are We There Yet?
    Irwin D; Saint-Hilaire M
    Neurology; 2021 May; 96(20):925-926. PubMed ID: 33858996
    [No Abstract]   [Full Text] [Related]  

  • 28. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
    Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
    Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.
    Peelaerts W; Bousset L; Van der Perren A; Moskalyuk A; Pulizzi R; Giugliano M; Van den Haute C; Melki R; Baekelandt V
    Nature; 2015 Jun; 522(7556):340-4. PubMed ID: 26061766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
    Peelaerts W; Baekelandt V
    J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
    Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
    Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
    Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
    J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. α-Synuclein: Experimental Pathology.
    Hasegawa M; Nonaka T; Masuda-Suzukake M
    Cold Spring Harb Perspect Med; 2016 Sep; 6(9):. PubMed ID: 27481772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging synucleinopathies.
    Brooks DJ; Tambasco N
    Mov Disord; 2016 Jun; 31(6):814-29. PubMed ID: 26879635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropathology underlying clinical variability in patients with synucleinopathies.
    Halliday GM; Holton JL; Revesz T; Dickson DW
    Acta Neuropathol; 2011 Aug; 122(2):187-204. PubMed ID: 21720849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. α-Synucleinopathy phenotypes.
    McCann H; Stevens CH; Cartwright H; Halliday GM
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S62-7. PubMed ID: 24262191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alpha-synucleinopathies].
    Ferrer I
    Neurologia; 2001 Apr; 16(4):163-70. PubMed ID: 11412709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-standing multiple system atrophy-Parkinsonism with limbic and FTLD-type α-synuclein pathology.
    Coughlin DG; Dryden I; Goodwill VS; Pizzo DP; Wright B; Lessig S; Galasko D; MacKenzie IR; Hiniker A
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12783. PubMed ID: 34847258
    [No Abstract]   [Full Text] [Related]  

  • 39. Up-regulation of SNCA gene expression: implications to synucleinopathies.
    Tagliafierro L; Chiba-Falek O
    Neurogenetics; 2016 Jul; 17(3):145-57. PubMed ID: 26948950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?
    Oueslati A
    J Parkinsons Dis; 2016; 6(1):39-51. PubMed ID: 27003784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.